Enzyme News and Research

RSS

NYITCOM research could potentially lead to more effective, less toxic cancer treatment

Patients undergoing conventional chemotherapy for certain cancers could potentially receive more effective and less toxic drug treatment.

9 Aug 2017

Scientists stop formation of protein clumps linked to ALS and frontotemporal dementia

Scientists report in a new study that by imitating a natural process of cells, they prevented the formation of protein clumps associated with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia.

8 Aug 2017

Newly discovered biomarker linked to rare metabolic disorders may facilitate better diagnosis

A newly discovered biomarker associated with a rare metabolic disorder may facilitate better diagnosis and identification of new drugs for clinical trials for the disease, according to researchers in the Perelman School of Medicine at the University of Pennsylvania.

7 Aug 2017

New way of screening compounds may help speed up drug development

Scientists have created a new way of screening compounds that is more sensitive than existing methods, opening up the possibility of finding new drugs for many diseases.

7 Aug 2017

Researchers hope to harness immune cells for better treatment of allergies, infections

By learning how a recently discovered immune cell works in the body, researchers hope to one day harness the cells to better treat allergies and infections, according to new Cornell University research.

4 Aug 2017

Omeros’ OMS721 receives orphan drug designation from FDA for treatment of IgA nephropathy

Omeros Corporation today announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Immunoglobulin A (IgA) nephropathy.

4 Aug 2017

IDT introduces first Cas9 enzyme variant that greatly reduces off-target effects in CRISPR genome editing

Integrated DNA Technologies today announced the launch of the first Cas9 enzyme variant that extensively reduces off-target effects in CRISPR genome editing without compromising on-target activity.

3 Aug 2017

Study shows new method for repairing disease-causing mutation in human embryos

Scientists have demonstrated an effective way of using a gene-editing tool to correct a disease-causing gene mutation in human embryos and stop it from passing to future generations.

3 Aug 2017

Researchers deliver knock-out blow to different types of cancer

Targeting healthy cells that have been hijacked by cancer cells could help treat many different types of the disease, according to research funded by Cancer Research UK and published in the Journal of the National Cancer Institute today (Thursday).

3 Aug 2017

Research shows great potential of embryonic gene editing to prevent inherited diseases

Scientists have, for the first time, corrected a disease-causing mutation in early stage human embryos with gene editing.

2 Aug 2017

Vanderbilt researchers unravel how bacterial toxin prevents DNA replication

One of the most potent toxins known acts by welding the two strands of the famous double helix together in a unique fashion which foils the standard repair mechanisms cells use to protect their DNA.

2 Aug 2017

Vanderbilt scientists find new way to destroy microbial vampires

On July 24 Vanderbilt scientist Eric Skaar, Ph.D., MPH, summarized his group's latest paper in a tweet: "If S. aureus is going to drink our blood like a vampire, let's kill it with sunlight."

1 Aug 2017

Simple blood test could help identify patients at greater risk of cardiac event after orthopedic surgery

A new study published today in the HSS Journal, the leading journal on musculoskeletal research, found the incidence of myocardial ischemia (defined by an elevated troponin level) after major orthopedic surgery in patients with cardiac risk factors is high, although the incidence of serious cardiac complications remains low.

31 Jul 2017

Enzyme News and Research

NYITCOM research could potentially lead to more effective, less toxic cancer treatment

Scientists stop formation of protein clumps linked to ALS and frontotemporal dementia

Newly discovered biomarker linked to rare metabolic disorders may facilitate better diagnosis

New way of screening compounds may help speed up drug development

Researchers hope to harness immune cells for better treatment of allergies, infections

Omeros’ OMS721 receives orphan drug designation from FDA for treatment of IgA nephropathy

IDT introduces first Cas9 enzyme variant that greatly reduces off-target effects in CRISPR genome editing

Study shows new method for repairing disease-causing mutation in human embryos

Researchers deliver knock-out blow to different types of cancer

Research shows great potential of embryonic gene editing to prevent inherited diseases

Vanderbilt researchers unravel how bacterial toxin prevents DNA replication

Vanderbilt scientists find new way to destroy microbial vampires

Simple blood test could help identify patients at greater risk of cardiac event after orthopedic surgery

DNA-sensing mechanism of innate immune system controls cellular senescence

New substance restores brain function in Alzheimer's animal model

Synthetic molecule can disrupt hunger-signaling pathway, research suggests

Gut bacterium can stop chemotherapy from causing cancer cell death

Neuro-oncology scientists discover unique molecular mechanism that maintains glioma stem cells

Princeton scientists test cell-culture system to aid study of HBV infections

Wistar scientists discover new therapeutic strategy for difficult-to-treat form of ovarian cancer

Biochemical Assays for Efficient Hit Prioritization After Screening eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo